These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2047378)

  • 1. Evaluation of the Shimada classification in advanced neuroblastoma with a special reference to the mitosis-karyorrhexis index: a report from the Childrens Cancer Study Group.
    Joshi VV; Chatten J; Sather HN; Shimada H
    Mod Pathol; 1991 Mar; 4(2):139-47. PubMed ID: 2047378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The International Neuroblastoma Pathology Classification (the Shimada system).
    Shimada H; Ambros IM; Dehner LP; Hata J; Joshi VV; Roald B; Stram DO; Gerbing RB; Lukens JN; Matthay KK; Castleberry RP
    Cancer; 1999 Jul; 86(2):364-72. PubMed ID: 10421273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modified histologic grading of neuroblastomas by replacement of mitotic rate with mitosis karyorrhexis index. A clinicopathologic study of 223 cases from the Pediatric Oncology Group.
    Joshi VV; Rao PV; Cantor AB; Altshuler G; Shuster JJ; Castleberry RP
    Cancer; 1996 Apr; 77(8):1582-8. PubMed ID: 8608547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
    Shimada H; Umehara S; Monobe Y; Hachitanda Y; Nakagawa A; Goto S; Gerbing RB; Stram DO; Lukens JN; Matthay KK
    Cancer; 2001 Nov; 92(9):2451-61. PubMed ID: 11745303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee.
    Shimada H; Ambros IM; Dehner LP; Hata J; Joshi VV; Roald B
    Cancer; 1999 Jul; 86(2):349-63. PubMed ID: 10421272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathology defines prognostic subsets of ganglioneuroblastoma, nodular.
    Umehara S; Nakagawa A; Matthay KK; Lukens JN; Seeger RC; Stram DO; Gerbing RB; Shimada H
    Cancer; 2000 Sep; 89(5):1150-61. PubMed ID: 10964346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-dependent prognostic effect by Mitosis-Karyorrhexis Index in neuroblastoma: a report from the Children's Oncology Group.
    Teshiba R; Kawano S; Wang LL; He L; Naranjo A; London WB; Seeger RC; Gastier-Foster JM; Look AT; Hogarty MD; Cohn SL; Maris JM; Park JR; Shimada H
    Pediatr Dev Pathol; 2014; 17(6):441-9. PubMed ID: 25207821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International neuroblastoma pathology classification adds independent prognostic information beyond the prognostic contribution of age.
    Sano H; Bonadio J; Gerbing RB; London WB; Matthay KK; Lukens JN; Shimada H
    Eur J Cancer; 2006 May; 42(8):1113-9. PubMed ID: 16624549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large cell neuroblastoma: a distinct phenotype of neuroblastoma with aggressive clinical behavior.
    Tornóczky T; Kálmán E; Kajtár PG; Nyári T; Pearson AD; Tweddle DA; Board J; Shimada H
    Cancer; 2004 Jan; 100(2):390-7. PubMed ID: 14716776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis.
    Shimada H; Stram DO; Chatten J; Joshi VV; Hachitanda Y; Brodeur GM; Lukens JN; Matthay KK; Seeger RC
    J Natl Cancer Inst; 1995 Oct; 87(19):1470-6. PubMed ID: 7674334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maturation of mass-screened localized adrenal neuroblastoma.
    Iwanaka T; Yamamoto K; Ogawa Y; Arai M; Ito M; Kishimoto H; Hanada R; Imaizumi S
    J Pediatr Surg; 2001 Nov; 36(11):1633-6. PubMed ID: 11685689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of the International Neuroblastoma Pathology Classification in Neuroblastoma (Schwannian stroma-poor) and comparison with other prognostic factors: a study of 182 cases from the Spanish Neuroblastoma Registry.
    Burgues O; Navarro S; Noguera R; Pellín A; Ruiz A; Castel V; Llombart-Bosch A
    Virchows Arch; 2006 Oct; 449(4):410-20. PubMed ID: 16941154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of International Neuroblastoma Pathology Classification in localized resectable peripheral neuroblastic tumors: a histopathologic study of localized neuroblastoma European Study Group 94.01 Trial and Protocol.
    Navarro S; Amann G; Beiske K; Cullinane CJ; d'Amore ES; Gambini C; Mosseri V; De Bernardi B; Michon J; Peuchmaur M;
    J Clin Oncol; 2006 Feb; 24(4):695-9. PubMed ID: 16446343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuroblastoma; biology and prognostic factors].
    Shimada H; Aotama C; Newton WA
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):44-9. PubMed ID: 3800408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of histopathology in advanced neuroblastoma: a report from the Childrens Cancer Study Group.
    Chatten J; Shimada H; Sather HN; Wong KY; Siegel SE; Hammond GD
    Hum Pathol; 1988 Oct; 19(10):1187-98. PubMed ID: 3169728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of the proliferative activity in neuroblastoma.
    Rudolph P; Lappe T; Hero B; Berthold F; Parwaresch R; Harms D; Schmidt D
    Am J Pathol; 1997 Jan; 150(1):133-45. PubMed ID: 9006330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MIB-1 Index as a Surrogate for Mitosis-Karyorrhexis Index in Neuroblastoma.
    Atikankul T; Atikankul Y; Santisukwongchote S; Marrano P; Shuangshoti S; Thorner PS
    Am J Surg Pathol; 2015 Aug; 39(8):1054-60. PubMed ID: 26171918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitosis-Karyorrhexis Index evaluation by digital image visual analysis for application of International Neuroblastoma Pathology Classification in FNA biopsy.
    Bhardwaj N; Rohilla M; Trehan A; Bansal D; Kakkar N; Srinivasan R
    Cancer Cytopathol; 2022 Feb; 130(2):128-135. PubMed ID: 34633743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project.
    Sokol E; Desai AV; Applebaum MA; Valteau-Couanet D; Park JR; Pearson ADJ; Schleiermacher G; Irwin MS; Hogarty M; Naranjo A; Volchenboum S; Cohn SL; London WB
    J Clin Oncol; 2020 Jun; 38(17):1906-1918. PubMed ID: 32315273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphologic features of neuroblastoma (Schwannian stroma-poor tumors) in clinically favorable and unfavorable groups.
    Ambros IM; Hata J; Joshi VV; Roald B; Dehner LP; Tüchler H; Pötschger U; Shimada H
    Cancer; 2002 Mar; 94(5):1574-83. PubMed ID: 11920516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.